nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophylline—CYP2E1—Dacarbazine—pancreatic cancer	0.12	0.219	CbGbCtD
Aminophylline—CYP2E1—Tamoxifen—pancreatic cancer	0.0955	0.174	CbGbCtD
Aminophylline—CYP1A2—Dacarbazine—pancreatic cancer	0.0694	0.127	CbGbCtD
Aminophylline—CYP1A2—Tamoxifen—pancreatic cancer	0.0552	0.101	CbGbCtD
Aminophylline—CYP1A2—Erlotinib—pancreatic cancer	0.047	0.0857	CbGbCtD
Aminophylline—CYP1A2—Fluorouracil—pancreatic cancer	0.0407	0.0742	CbGbCtD
Aminophylline—CYP3A4—Tamoxifen—pancreatic cancer	0.0289	0.0528	CbGbCtD
Aminophylline—CYP3A4—Erlotinib—pancreatic cancer	0.0246	0.0449	CbGbCtD
Aminophylline—CYP3A4—Irinotecan—pancreatic cancer	0.0222	0.0405	CbGbCtD
Aminophylline—CYP3A4—Docetaxel—pancreatic cancer	0.0163	0.0297	CbGbCtD
Aminophylline—CYP3A4—Sunitinib—pancreatic cancer	0.0162	0.0296	CbGbCtD
Aminophylline—CYP3A4—Doxorubicin—pancreatic cancer	0.0121	0.0221	CbGbCtD
Aminophylline—HDAC2—Topotecan—Irinotecan—pancreatic cancer	0.005	0.598	CbGdCrCtD
Aminophylline—HDAC2—Gefitinib—Erlotinib—pancreatic cancer	0.00337	0.402	CbGdCrCtD
Aminophylline—Lightheadedness—Docetaxel—pancreatic cancer	0.000886	0.00459	CcSEcCtD
Aminophylline—Ventricular arrhythmia—Doxorubicin—pancreatic cancer	0.000835	0.00432	CcSEcCtD
Aminophylline—Phlebitis—Docetaxel—pancreatic cancer	0.000834	0.00432	CcSEcCtD
Aminophylline—Albuminuria—Doxorubicin—pancreatic cancer	0.000828	0.00429	CcSEcCtD
Aminophylline—Flushing—Sunitinib—pancreatic cancer	0.000811	0.0042	CcSEcCtD
Aminophylline—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.00079	0.00409	CcSEcCtD
Aminophylline—Arrhythmia—Sunitinib—pancreatic cancer	0.00078	0.00404	CcSEcCtD
Aminophylline—Alopecia—Sunitinib—pancreatic cancer	0.000772	0.004	CcSEcCtD
Aminophylline—Extravasation—Epirubicin—pancreatic cancer	0.000766	0.00396	CcSEcCtD
Aminophylline—Atrial fibrillation—Docetaxel—pancreatic cancer	0.000759	0.00393	CcSEcCtD
Aminophylline—Anxiety—Tamoxifen—pancreatic cancer	0.000753	0.0039	CcSEcCtD
Aminophylline—Anxiety—Erlotinib—pancreatic cancer	0.000745	0.00386	CcSEcCtD
Aminophylline—Haematuria—Gemcitabine—pancreatic cancer	0.000744	0.00385	CcSEcCtD
Aminophylline—Ventricular extrasystoles—Epirubicin—pancreatic cancer	0.00074	0.00383	CcSEcCtD
Aminophylline—Hyperuricaemia—Epirubicin—pancreatic cancer	0.00072	0.00373	CcSEcCtD
Aminophylline—Infection—Tamoxifen—pancreatic cancer	0.00072	0.00373	CcSEcCtD
Aminophylline—Infection—Erlotinib—pancreatic cancer	0.000712	0.00369	CcSEcCtD
Aminophylline—Extravasation—Doxorubicin—pancreatic cancer	0.000708	0.00367	CcSEcCtD
Aminophylline—Shock—Erlotinib—pancreatic cancer	0.000705	0.00365	CcSEcCtD
Aminophylline—Nervous system disorder—Erlotinib—pancreatic cancer	0.000703	0.00364	CcSEcCtD
Aminophylline—Anorexia—Tamoxifen—pancreatic cancer	0.000691	0.00358	CcSEcCtD
Aminophylline—Ventricular extrasystoles—Doxorubicin—pancreatic cancer	0.000684	0.00354	CcSEcCtD
Aminophylline—Anorexia—Erlotinib—pancreatic cancer	0.000683	0.00354	CcSEcCtD
Aminophylline—Blood uric acid increased—Epirubicin—pancreatic cancer	0.00068	0.00352	CcSEcCtD
Aminophylline—Flushing—Irinotecan—pancreatic cancer	0.000668	0.00346	CcSEcCtD
Aminophylline—Hyperuricaemia—Doxorubicin—pancreatic cancer	0.000666	0.00345	CcSEcCtD
Aminophylline—Dermatitis contact—Epirubicin—pancreatic cancer	0.00066	0.00342	CcSEcCtD
Aminophylline—Convulsion—Sunitinib—pancreatic cancer	0.000659	0.00341	CcSEcCtD
Aminophylline—Abdominal pain upper—Docetaxel—pancreatic cancer	0.000657	0.0034	CcSEcCtD
Aminophylline—Insomnia—Tamoxifen—pancreatic cancer	0.000655	0.00339	CcSEcCtD
Aminophylline—Insomnia—Erlotinib—pancreatic cancer	0.000648	0.00336	CcSEcCtD
Aminophylline—Arrhythmia—Irinotecan—pancreatic cancer	0.000643	0.00333	CcSEcCtD
Aminophylline—Skin exfoliation—Epirubicin—pancreatic cancer	0.000638	0.0033	CcSEcCtD
Aminophylline—Dyspepsia—Tamoxifen—pancreatic cancer	0.000638	0.0033	CcSEcCtD
Aminophylline—Alopecia—Irinotecan—pancreatic cancer	0.000636	0.00329	CcSEcCtD
Aminophylline—Dyspepsia—Erlotinib—pancreatic cancer	0.000631	0.00327	CcSEcCtD
Aminophylline—Decreased appetite—Tamoxifen—pancreatic cancer	0.00063	0.00326	CcSEcCtD
Aminophylline—Blood uric acid increased—Doxorubicin—pancreatic cancer	0.000629	0.00326	CcSEcCtD
Aminophylline—Arrhythmia—Gemcitabine—pancreatic cancer	0.000626	0.00324	CcSEcCtD
Aminophylline—Decreased appetite—Erlotinib—pancreatic cancer	0.000623	0.00323	CcSEcCtD
Aminophylline—Alopecia—Gemcitabine—pancreatic cancer	0.000619	0.00321	CcSEcCtD
Aminophylline—Infection—Sunitinib—pancreatic cancer	0.000616	0.00319	CcSEcCtD
Aminophylline—Arrhythmia—Fluorouracil—pancreatic cancer	0.000616	0.00319	CcSEcCtD
Aminophylline—Dermatitis contact—Doxorubicin—pancreatic cancer	0.000611	0.00316	CcSEcCtD
Aminophylline—Shock—Sunitinib—pancreatic cancer	0.00061	0.00316	CcSEcCtD
Aminophylline—Coma—Epirubicin—pancreatic cancer	0.00061	0.00316	CcSEcCtD
Aminophylline—Alopecia—Fluorouracil—pancreatic cancer	0.000609	0.00315	CcSEcCtD
Aminophylline—Nervous system disorder—Sunitinib—pancreatic cancer	0.000608	0.00315	CcSEcCtD
Aminophylline—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000592	0.00307	CcSEcCtD
Aminophylline—Anorexia—Sunitinib—pancreatic cancer	0.000591	0.00306	CcSEcCtD
Aminophylline—Skin exfoliation—Doxorubicin—pancreatic cancer	0.00059	0.00305	CcSEcCtD
Aminophylline—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000586	0.00303	CcSEcCtD
Aminophylline—Urticaria—Tamoxifen—pancreatic cancer	0.000576	0.00298	CcSEcCtD
Aminophylline—Abdominal pain—Tamoxifen—pancreatic cancer	0.000573	0.00297	CcSEcCtD
Aminophylline—Abdominal pain—Erlotinib—pancreatic cancer	0.000567	0.00293	CcSEcCtD
Aminophylline—Body temperature increased—Erlotinib—pancreatic cancer	0.000567	0.00293	CcSEcCtD
Aminophylline—Coma—Doxorubicin—pancreatic cancer	0.000565	0.00292	CcSEcCtD
Aminophylline—Phlebitis—Epirubicin—pancreatic cancer	0.000563	0.00291	CcSEcCtD
Aminophylline—Insomnia—Sunitinib—pancreatic cancer	0.000561	0.00291	CcSEcCtD
Aminophylline—Dyspepsia—Sunitinib—pancreatic cancer	0.000546	0.00283	CcSEcCtD
Aminophylline—Decreased appetite—Sunitinib—pancreatic cancer	0.000539	0.00279	CcSEcCtD
Aminophylline—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000534	0.00276	CcSEcCtD
Aminophylline—Phlebitis—Doxorubicin—pancreatic cancer	0.000521	0.0027	CcSEcCtD
Aminophylline—Convulsion—Fluorouracil—pancreatic cancer	0.00052	0.00269	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.000514	0.00266	CcSEcCtD
Aminophylline—Pruritus—Tamoxifen—pancreatic cancer	0.000513	0.00265	CcSEcCtD
Aminophylline—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000511	0.00265	CcSEcCtD
Aminophylline—Infection—Irinotecan—pancreatic cancer	0.000508	0.00263	CcSEcCtD
Aminophylline—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000507	0.00263	CcSEcCtD
Aminophylline—Pruritus—Erlotinib—pancreatic cancer	0.000507	0.00263	CcSEcCtD
Aminophylline—Shock—Irinotecan—pancreatic cancer	0.000503	0.0026	CcSEcCtD
Aminophylline—Nervous system disorder—Irinotecan—pancreatic cancer	0.000501	0.0026	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000501	0.00259	CcSEcCtD
Aminophylline—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000498	0.00258	CcSEcCtD
Aminophylline—Diarrhoea—Tamoxifen—pancreatic cancer	0.000496	0.00257	CcSEcCtD
Aminophylline—Infection—Gemcitabine—pancreatic cancer	0.000495	0.00256	CcSEcCtD
Aminophylline—Abdominal pain—Sunitinib—pancreatic cancer	0.00049	0.00254	CcSEcCtD
Aminophylline—Body temperature increased—Sunitinib—pancreatic cancer	0.00049	0.00254	CcSEcCtD
Aminophylline—Diarrhoea—Erlotinib—pancreatic cancer	0.00049	0.00254	CcSEcCtD
Aminophylline—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00049	0.00253	CcSEcCtD
Aminophylline—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000488	0.00253	CcSEcCtD
Aminophylline—Anorexia—Irinotecan—pancreatic cancer	0.000487	0.00252	CcSEcCtD
Aminophylline—Infection—Fluorouracil—pancreatic cancer	0.000486	0.00252	CcSEcCtD
Aminophylline—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00048	0.00249	CcSEcCtD
Aminophylline—Dizziness—Tamoxifen—pancreatic cancer	0.000479	0.00248	CcSEcCtD
Aminophylline—Tachycardia—Fluorouracil—pancreatic cancer	0.000478	0.00247	CcSEcCtD
Aminophylline—Hypotension—Irinotecan—pancreatic cancer	0.000478	0.00247	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000475	0.00246	CcSEcCtD
Aminophylline—Anorexia—Gemcitabine—pancreatic cancer	0.000475	0.00246	CcSEcCtD
Aminophylline—Dizziness—Erlotinib—pancreatic cancer	0.000474	0.00245	CcSEcCtD
Aminophylline—Anorexia—Fluorouracil—pancreatic cancer	0.000467	0.00242	CcSEcCtD
Aminophylline—Hypotension—Gemcitabine—pancreatic cancer	0.000465	0.00241	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000464	0.0024	CcSEcCtD
Aminophylline—Insomnia—Irinotecan—pancreatic cancer	0.000462	0.00239	CcSEcCtD
Aminophylline—Flushing—Docetaxel—pancreatic cancer	0.000462	0.00239	CcSEcCtD
Aminophylline—Vomiting—Tamoxifen—pancreatic cancer	0.000461	0.00238	CcSEcCtD
Aminophylline—Hypotension—Fluorouracil—pancreatic cancer	0.000457	0.00237	CcSEcCtD
Aminophylline—Hypersensitivity—Sunitinib—pancreatic cancer	0.000457	0.00237	CcSEcCtD
Aminophylline—Rash—Tamoxifen—pancreatic cancer	0.000457	0.00236	CcSEcCtD
Aminophylline—Dermatitis—Tamoxifen—pancreatic cancer	0.000456	0.00236	CcSEcCtD
Aminophylline—Vomiting—Erlotinib—pancreatic cancer	0.000456	0.00236	CcSEcCtD
Aminophylline—Headache—Tamoxifen—pancreatic cancer	0.000454	0.00235	CcSEcCtD
Aminophylline—Rash—Erlotinib—pancreatic cancer	0.000452	0.00234	CcSEcCtD
Aminophylline—Dermatitis—Erlotinib—pancreatic cancer	0.000452	0.00234	CcSEcCtD
Aminophylline—Insomnia—Gemcitabine—pancreatic cancer	0.00045	0.00233	CcSEcCtD
Aminophylline—Dyspepsia—Irinotecan—pancreatic cancer	0.00045	0.00233	CcSEcCtD
Aminophylline—Headache—Erlotinib—pancreatic cancer	0.000449	0.00232	CcSEcCtD
Aminophylline—Decreased appetite—Irinotecan—pancreatic cancer	0.000444	0.0023	CcSEcCtD
Aminophylline—Arrhythmia—Docetaxel—pancreatic cancer	0.000444	0.0023	CcSEcCtD
Aminophylline—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000443	0.00229	CcSEcCtD
Aminophylline—Insomnia—Fluorouracil—pancreatic cancer	0.000443	0.00229	CcSEcCtD
Aminophylline—Hypokalaemia—Epirubicin—pancreatic cancer	0.000441	0.00228	CcSEcCtD
Aminophylline—Alopecia—Docetaxel—pancreatic cancer	0.000439	0.00228	CcSEcCtD
Aminophylline—Pruritus—Sunitinib—pancreatic cancer	0.000439	0.00227	CcSEcCtD
Aminophylline—Decreased appetite—Gemcitabine—pancreatic cancer	0.000433	0.00224	CcSEcCtD
Aminophylline—Dyspepsia—Fluorouracil—pancreatic cancer	0.000431	0.00223	CcSEcCtD
Aminophylline—Nausea—Tamoxifen—pancreatic cancer	0.00043	0.00223	CcSEcCtD
Aminophylline—Nausea—Erlotinib—pancreatic cancer	0.000426	0.0022	CcSEcCtD
Aminophylline—Decreased appetite—Fluorouracil—pancreatic cancer	0.000426	0.0022	CcSEcCtD
Aminophylline—Diarrhoea—Sunitinib—pancreatic cancer	0.000425	0.0022	CcSEcCtD
Aminophylline—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000418	0.00216	CcSEcCtD
Aminophylline—Dizziness—Sunitinib—pancreatic cancer	0.00041	0.00212	CcSEcCtD
Aminophylline—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.00041	0.00212	CcSEcCtD
Aminophylline—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000408	0.00211	CcSEcCtD
Aminophylline—Abdominal pain—Irinotecan—pancreatic cancer	0.000404	0.00209	CcSEcCtD
Aminophylline—Body temperature increased—Irinotecan—pancreatic cancer	0.000404	0.00209	CcSEcCtD
Aminophylline—Vomiting—Sunitinib—pancreatic cancer	0.000395	0.00204	CcSEcCtD
Aminophylline—Body temperature increased—Gemcitabine—pancreatic cancer	0.000394	0.00204	CcSEcCtD
Aminophylline—Rash—Sunitinib—pancreatic cancer	0.000391	0.00203	CcSEcCtD
Aminophylline—Dermatitis—Sunitinib—pancreatic cancer	0.000391	0.00202	CcSEcCtD
Aminophylline—Urticaria—Fluorouracil—pancreatic cancer	0.000389	0.00201	CcSEcCtD
Aminophylline—Headache—Sunitinib—pancreatic cancer	0.000389	0.00201	CcSEcCtD
Aminophylline—Body temperature increased—Fluorouracil—pancreatic cancer	0.000387	0.002	CcSEcCtD
Aminophylline—Palpitations—Docetaxel—pancreatic cancer	0.000383	0.00198	CcSEcCtD
Aminophylline—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000378	0.00196	CcSEcCtD
Aminophylline—Hypersensitivity—Irinotecan—pancreatic cancer	0.000377	0.00195	CcSEcCtD
Aminophylline—Convulsion—Docetaxel—pancreatic cancer	0.000375	0.00194	CcSEcCtD
Aminophylline—Nausea—Sunitinib—pancreatic cancer	0.000369	0.00191	CcSEcCtD
Aminophylline—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000361	0.00187	CcSEcCtD
Aminophylline—Haematuria—Epirubicin—pancreatic cancer	0.000356	0.00184	CcSEcCtD
Aminophylline—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000353	0.00183	CcSEcCtD
Aminophylline—Pruritus—Gemcitabine—pancreatic cancer	0.000352	0.00182	CcSEcCtD
Aminophylline—Infection—Docetaxel—pancreatic cancer	0.000351	0.00182	CcSEcCtD
Aminophylline—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.00035	0.00181	CcSEcCtD
Aminophylline—Diarrhoea—Irinotecan—pancreatic cancer	0.00035	0.00181	CcSEcCtD
Aminophylline—Shock—Docetaxel—pancreatic cancer	0.000348	0.0018	CcSEcCtD
Aminophylline—Nervous system disorder—Docetaxel—pancreatic cancer	0.000346	0.00179	CcSEcCtD
Aminophylline—Pruritus—Fluorouracil—pancreatic cancer	0.000346	0.00179	CcSEcCtD
Aminophylline—Tachycardia—Docetaxel—pancreatic cancer	0.000345	0.00179	CcSEcCtD
Aminophylline—Diarrhoea—Gemcitabine—pancreatic cancer	0.000341	0.00176	CcSEcCtD
Aminophylline—Dizziness—Irinotecan—pancreatic cancer	0.000338	0.00175	CcSEcCtD
Aminophylline—Anorexia—Docetaxel—pancreatic cancer	0.000337	0.00174	CcSEcCtD
Aminophylline—Diarrhoea—Fluorouracil—pancreatic cancer	0.000335	0.00173	CcSEcCtD
Aminophylline—Hypotension—Docetaxel—pancreatic cancer	0.00033	0.00171	CcSEcCtD
Aminophylline—Haematuria—Doxorubicin—pancreatic cancer	0.00033	0.00171	CcSEcCtD
Aminophylline—Vomiting—Irinotecan—pancreatic cancer	0.000325	0.00168	CcSEcCtD
Aminophylline—Dizziness—Fluorouracil—pancreatic cancer	0.000324	0.00168	CcSEcCtD
Aminophylline—Rash—Irinotecan—pancreatic cancer	0.000322	0.00167	CcSEcCtD
Aminophylline—Dermatitis—Irinotecan—pancreatic cancer	0.000322	0.00167	CcSEcCtD
Aminophylline—Headache—Irinotecan—pancreatic cancer	0.00032	0.00166	CcSEcCtD
Aminophylline—Insomnia—Docetaxel—pancreatic cancer	0.00032	0.00165	CcSEcCtD
Aminophylline—Vomiting—Gemcitabine—pancreatic cancer	0.000317	0.00164	CcSEcCtD
Aminophylline—Rash—Gemcitabine—pancreatic cancer	0.000314	0.00163	CcSEcCtD
Aminophylline—Dermatitis—Gemcitabine—pancreatic cancer	0.000314	0.00162	CcSEcCtD
Aminophylline—Headache—Gemcitabine—pancreatic cancer	0.000312	0.00161	CcSEcCtD
Aminophylline—Flushing—Epirubicin—pancreatic cancer	0.000311	0.00161	CcSEcCtD
Aminophylline—Vomiting—Fluorouracil—pancreatic cancer	0.000311	0.00161	CcSEcCtD
Aminophylline—Dyspepsia—Docetaxel—pancreatic cancer	0.000311	0.00161	CcSEcCtD
Aminophylline—Rash—Fluorouracil—pancreatic cancer	0.000309	0.0016	CcSEcCtD
Aminophylline—Dermatitis—Fluorouracil—pancreatic cancer	0.000308	0.0016	CcSEcCtD
Aminophylline—Decreased appetite—Docetaxel—pancreatic cancer	0.000307	0.00159	CcSEcCtD
Aminophylline—Headache—Fluorouracil—pancreatic cancer	0.000307	0.00159	CcSEcCtD
Aminophylline—Nausea—Irinotecan—pancreatic cancer	0.000304	0.00157	CcSEcCtD
Aminophylline—Arrhythmia—Epirubicin—pancreatic cancer	0.0003	0.00155	CcSEcCtD
Aminophylline—Alopecia—Epirubicin—pancreatic cancer	0.000296	0.00153	CcSEcCtD
Aminophylline—Nausea—Gemcitabine—pancreatic cancer	0.000296	0.00153	CcSEcCtD
Aminophylline—Nausea—Fluorouracil—pancreatic cancer	0.000291	0.00151	CcSEcCtD
Aminophylline—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000289	0.0015	CcSEcCtD
Aminophylline—Flushing—Doxorubicin—pancreatic cancer	0.000288	0.00149	CcSEcCtD
Aminophylline—Tension—Epirubicin—pancreatic cancer	0.000287	0.00148	CcSEcCtD
Aminophylline—Nervousness—Epirubicin—pancreatic cancer	0.000284	0.00147	CcSEcCtD
Aminophylline—Abdominal pain—Docetaxel—pancreatic cancer	0.000279	0.00145	CcSEcCtD
Aminophylline—Body temperature increased—Docetaxel—pancreatic cancer	0.000279	0.00145	CcSEcCtD
Aminophylline—Arrhythmia—Doxorubicin—pancreatic cancer	0.000277	0.00144	CcSEcCtD
Aminophylline—Alopecia—Doxorubicin—pancreatic cancer	0.000274	0.00142	CcSEcCtD
Aminophylline—Agitation—Epirubicin—pancreatic cancer	0.000268	0.00139	CcSEcCtD
Aminophylline—Tension—Doxorubicin—pancreatic cancer	0.000265	0.00137	CcSEcCtD
Aminophylline—Nervousness—Doxorubicin—pancreatic cancer	0.000262	0.00136	CcSEcCtD
Aminophylline—Hypersensitivity—Docetaxel—pancreatic cancer	0.00026	0.00135	CcSEcCtD
Aminophylline—Palpitations—Epirubicin—pancreatic cancer	0.000258	0.00134	CcSEcCtD
Aminophylline—Convulsion—Epirubicin—pancreatic cancer	0.000253	0.00131	CcSEcCtD
Aminophylline—Pruritus—Docetaxel—pancreatic cancer	0.00025	0.00129	CcSEcCtD
Aminophylline—Agitation—Doxorubicin—pancreatic cancer	0.000248	0.00129	CcSEcCtD
Aminophylline—Anxiety—Epirubicin—pancreatic cancer	0.000248	0.00128	CcSEcCtD
Aminophylline—Diarrhoea—Docetaxel—pancreatic cancer	0.000242	0.00125	CcSEcCtD
Aminophylline—Palpitations—Doxorubicin—pancreatic cancer	0.000239	0.00124	CcSEcCtD
Aminophylline—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000238	0.00123	CcSEcCtD
Aminophylline—Infection—Epirubicin—pancreatic cancer	0.000237	0.00123	CcSEcCtD
Aminophylline—Shock—Epirubicin—pancreatic cancer	0.000234	0.00121	CcSEcCtD
Aminophylline—Convulsion—Doxorubicin—pancreatic cancer	0.000234	0.00121	CcSEcCtD
Aminophylline—Nervous system disorder—Epirubicin—pancreatic cancer	0.000234	0.00121	CcSEcCtD
Aminophylline—Dizziness—Docetaxel—pancreatic cancer	0.000234	0.00121	CcSEcCtD
Aminophylline—Tachycardia—Epirubicin—pancreatic cancer	0.000233	0.0012	CcSEcCtD
Aminophylline—Anxiety—Doxorubicin—pancreatic cancer	0.000229	0.00119	CcSEcCtD
Aminophylline—Anorexia—Epirubicin—pancreatic cancer	0.000227	0.00118	CcSEcCtD
Aminophylline—Vomiting—Docetaxel—pancreatic cancer	0.000225	0.00116	CcSEcCtD
Aminophylline—Rash—Docetaxel—pancreatic cancer	0.000223	0.00115	CcSEcCtD
Aminophylline—Hypotension—Epirubicin—pancreatic cancer	0.000223	0.00115	CcSEcCtD
Aminophylline—Dermatitis—Docetaxel—pancreatic cancer	0.000223	0.00115	CcSEcCtD
Aminophylline—Headache—Docetaxel—pancreatic cancer	0.000221	0.00115	CcSEcCtD
Aminophylline—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000221	0.00114	CcSEcCtD
Aminophylline—Infection—Doxorubicin—pancreatic cancer	0.000219	0.00113	CcSEcCtD
Aminophylline—Shock—Doxorubicin—pancreatic cancer	0.000217	0.00112	CcSEcCtD
Aminophylline—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000216	0.00112	CcSEcCtD
Aminophylline—Insomnia—Epirubicin—pancreatic cancer	0.000216	0.00112	CcSEcCtD
Aminophylline—Tachycardia—Doxorubicin—pancreatic cancer	0.000215	0.00111	CcSEcCtD
Aminophylline—Anorexia—Doxorubicin—pancreatic cancer	0.00021	0.00109	CcSEcCtD
Aminophylline—Nausea—Docetaxel—pancreatic cancer	0.00021	0.00109	CcSEcCtD
Aminophylline—Dyspepsia—Epirubicin—pancreatic cancer	0.00021	0.00109	CcSEcCtD
Aminophylline—Decreased appetite—Epirubicin—pancreatic cancer	0.000207	0.00107	CcSEcCtD
Aminophylline—Hypotension—Doxorubicin—pancreatic cancer	0.000206	0.00107	CcSEcCtD
Aminophylline—Insomnia—Doxorubicin—pancreatic cancer	0.000199	0.00103	CcSEcCtD
Aminophylline—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000195	0.00101	CcSEcCtD
Aminophylline—Dyspepsia—Doxorubicin—pancreatic cancer	0.000194	0.001	CcSEcCtD
Aminophylline—Decreased appetite—Doxorubicin—pancreatic cancer	0.000192	0.000992	CcSEcCtD
Aminophylline—Urticaria—Epirubicin—pancreatic cancer	0.000189	0.00098	CcSEcCtD
Aminophylline—Abdominal pain—Epirubicin—pancreatic cancer	0.000188	0.000975	CcSEcCtD
Aminophylline—Body temperature increased—Epirubicin—pancreatic cancer	0.000188	0.000975	CcSEcCtD
Aminophylline—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00018	0.000934	CcSEcCtD
Aminophylline—Hypersensitivity—Epirubicin—pancreatic cancer	0.000176	0.000909	CcSEcCtD
Aminophylline—Urticaria—Doxorubicin—pancreatic cancer	0.000175	0.000907	CcSEcCtD
Aminophylline—Body temperature increased—Doxorubicin—pancreatic cancer	0.000174	0.000902	CcSEcCtD
Aminophylline—Abdominal pain—Doxorubicin—pancreatic cancer	0.000174	0.000902	CcSEcCtD
Aminophylline—Pruritus—Epirubicin—pancreatic cancer	0.000169	0.000873	CcSEcCtD
Aminophylline—Diarrhoea—Epirubicin—pancreatic cancer	0.000163	0.000844	CcSEcCtD
Aminophylline—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000162	0.000841	CcSEcCtD
Aminophylline—Dizziness—Epirubicin—pancreatic cancer	0.000158	0.000816	CcSEcCtD
Aminophylline—Pruritus—Doxorubicin—pancreatic cancer	0.000156	0.000808	CcSEcCtD
Aminophylline—Vomiting—Epirubicin—pancreatic cancer	0.000152	0.000784	CcSEcCtD
Aminophylline—Diarrhoea—Doxorubicin—pancreatic cancer	0.000151	0.000781	CcSEcCtD
Aminophylline—Rash—Epirubicin—pancreatic cancer	0.00015	0.000778	CcSEcCtD
Aminophylline—Dermatitis—Epirubicin—pancreatic cancer	0.00015	0.000777	CcSEcCtD
Aminophylline—Headache—Epirubicin—pancreatic cancer	0.000149	0.000773	CcSEcCtD
Aminophylline—Dizziness—Doxorubicin—pancreatic cancer	0.000146	0.000755	CcSEcCtD
Aminophylline—Nausea—Epirubicin—pancreatic cancer	0.000142	0.000733	CcSEcCtD
Aminophylline—Vomiting—Doxorubicin—pancreatic cancer	0.00014	0.000726	CcSEcCtD
Aminophylline—Rash—Doxorubicin—pancreatic cancer	0.000139	0.00072	CcSEcCtD
Aminophylline—Dermatitis—Doxorubicin—pancreatic cancer	0.000139	0.000719	CcSEcCtD
Aminophylline—Headache—Doxorubicin—pancreatic cancer	0.000138	0.000715	CcSEcCtD
Aminophylline—Nausea—Doxorubicin—pancreatic cancer	0.000131	0.000678	CcSEcCtD
Aminophylline—ADORA1—Signaling Pathways—PIK3CG—pancreatic cancer	3.58e-05	0.000143	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—NRAS—pancreatic cancer	3.58e-05	0.000143	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—EGF—pancreatic cancer	3.54e-05	0.000141	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TERT—pancreatic cancer	3.53e-05	0.000141	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—EGFR—pancreatic cancer	3.49e-05	0.000139	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—SLC2A2—pancreatic cancer	3.47e-05	0.000138	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—CXCL8—pancreatic cancer	3.45e-05	0.000138	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—EGFR—pancreatic cancer	3.39e-05	0.000135	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—HIF1A—pancreatic cancer	3.38e-05	0.000135	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TSC2—pancreatic cancer	3.37e-05	0.000135	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—PIK3CD—pancreatic cancer	3.36e-05	0.000134	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—AKT1—pancreatic cancer	3.35e-05	0.000134	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—PIK3CA—pancreatic cancer	3.33e-05	0.000133	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.33e-05	0.000133	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—APOE—pancreatic cancer	3.3e-05	0.000132	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—KRAS—pancreatic cancer	3.29e-05	0.000132	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TERT—pancreatic cancer	3.28e-05	0.000131	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PIK3CD—pancreatic cancer	3.27e-05	0.000131	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—EGFR—pancreatic cancer	3.26e-05	0.00013	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PIK3CB—pancreatic cancer	3.26e-05	0.00013	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.24e-05	0.000129	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KDR—pancreatic cancer	3.23e-05	0.000129	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—PIK3CB—pancreatic cancer	3.23e-05	0.000129	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PTGS2—pancreatic cancer	3.23e-05	0.000129	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—KRAS—pancreatic cancer	3.2e-05	0.000128	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ARG2—pancreatic cancer	3.17e-05	0.000127	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PIK3CD—pancreatic cancer	3.15e-05	0.000126	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—HIF1A—pancreatic cancer	3.14e-05	0.000125	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TSC2—pancreatic cancer	3.13e-05	0.000125	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.12e-05	0.000125	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CXCL8—pancreatic cancer	3.1e-05	0.000124	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—KRAS—pancreatic cancer	3.08e-05	0.000123	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—HRAS—pancreatic cancer	3.08e-05	0.000123	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NFKBIA—pancreatic cancer	3.07e-05	0.000123	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—APOE—pancreatic cancer	3.06e-05	0.000122	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NOTCH1—pancreatic cancer	3.04e-05	0.000122	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—PIK3CA—pancreatic cancer	3.03e-05	0.000121	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—KDR—pancreatic cancer	3e-05	0.00012	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—AKT1—pancreatic cancer	3e-05	0.00012	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PIK3CG—pancreatic cancer	2.98e-05	0.000119	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CASP3—pancreatic cancer	2.97e-05	0.000119	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—PIK3CA—pancreatic cancer	2.94e-05	0.000118	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—EGF—pancreatic cancer	2.94e-05	0.000117	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—PIK3CB—pancreatic cancer	2.93e-05	0.000117	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CCND1—pancreatic cancer	2.89e-05	0.000115	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CTNNB1—pancreatic cancer	2.89e-05	0.000115	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CTNNB1—pancreatic cancer	2.86e-05	0.000114	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NFKBIA—pancreatic cancer	2.86e-05	0.000114	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PIK3CB—pancreatic cancer	2.85e-05	0.000114	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—PIK3CA—pancreatic cancer	2.83e-05	0.000113	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NOTCH1—pancreatic cancer	2.83e-05	0.000113	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.82e-05	0.000113	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CXCL8—pancreatic cancer	2.82e-05	0.000113	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PTEN—pancreatic cancer	2.81e-05	0.000112	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MMP9—pancreatic cancer	2.81e-05	0.000112	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—HRAS—pancreatic cancer	2.8e-05	0.000112	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—PTEN—pancreatic cancer	2.79e-05	0.000111	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—TYMP—pancreatic cancer	2.77e-05	0.000111	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3CG—pancreatic cancer	2.77e-05	0.00011	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—NRAS—pancreatic cancer	2.77e-05	0.00011	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PIK3CB—pancreatic cancer	2.75e-05	0.00011	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CXCL8—pancreatic cancer	2.74e-05	0.000109	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—EGF—pancreatic cancer	2.73e-05	0.000109	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—HRAS—pancreatic cancer	2.72e-05	0.000109	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—AKT1—pancreatic cancer	2.72e-05	0.000109	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—AKT1—pancreatic cancer	2.72e-05	0.000109	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CASP3—pancreatic cancer	2.7e-05	0.000108	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CD44—pancreatic cancer	2.68e-05	0.000107	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—AKT1—pancreatic cancer	2.65e-05	0.000106	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CXCL8—pancreatic cancer	2.64e-05	0.000105	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CCND1—pancreatic cancer	2.62e-05	0.000105	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CASP3—pancreatic cancer	2.62e-05	0.000105	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—HRAS—pancreatic cancer	2.62e-05	0.000105	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PIK3CD—pancreatic cancer	2.62e-05	0.000104	CbGpPWpGaD
Aminophylline—HDAC2—Disease—SRC—pancreatic cancer	2.61e-05	0.000104	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CTNNB1—pancreatic cancer	2.6e-05	0.000104	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—SRC—pancreatic cancer	2.59e-05	0.000103	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GCG—pancreatic cancer	2.57e-05	0.000103	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CCND1—pancreatic cancer	2.55e-05	0.000102	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—AKT1—pancreatic cancer	2.55e-05	0.000102	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MMP9—pancreatic cancer	2.55e-05	0.000102	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—PTEN—pancreatic cancer	2.53e-05	0.000101	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CTNNB1—pancreatic cancer	2.53e-05	0.000101	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CASP3—pancreatic cancer	2.52e-05	0.000101	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—EGFR—pancreatic cancer	2.52e-05	0.000101	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—VEGFA—pancreatic cancer	2.52e-05	0.000101	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—MYC—pancreatic cancer	2.52e-05	0.000101	CbGpPWpGaD
Aminophylline—HDAC2—Disease—STAT3—pancreatic cancer	2.52e-05	0.000101	CbGpPWpGaD
Aminophylline—HDAC2—Disease—NRAS—pancreatic cancer	2.51e-05	0.0001	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—STAT3—pancreatic cancer	2.5e-05	9.97e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—NRAS—pancreatic cancer	2.49e-05	9.94e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MMP9—pancreatic cancer	2.48e-05	9.9e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—AKT1—pancreatic cancer	2.47e-05	9.87e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PTEN—pancreatic cancer	2.46e-05	9.84e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCND1—pancreatic cancer	2.46e-05	9.82e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ARG2—pancreatic cancer	2.44e-05	9.76e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CTNNB1—pancreatic cancer	2.43e-05	9.72e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3CD—pancreatic cancer	2.43e-05	9.71e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—STK11—pancreatic cancer	2.42e-05	9.66e-05	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.41e-05	9.62e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—AKT1—pancreatic cancer	2.4e-05	9.6e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MMP9—pancreatic cancer	2.39e-05	9.53e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—KRAS—pancreatic cancer	2.38e-05	9.51e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PTEN—pancreatic cancer	2.37e-05	9.48e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—SRC—pancreatic cancer	2.35e-05	9.38e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—MYC—pancreatic cancer	2.34e-05	9.34e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—TGFB1—pancreatic cancer	2.33e-05	9.32e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MYC—pancreatic cancer	2.32e-05	9.26e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—AKT1—pancreatic cancer	2.31e-05	9.24e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TGFB1—pancreatic cancer	2.31e-05	9.24e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—VEGFA—pancreatic cancer	2.29e-05	9.14e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—EGFR—pancreatic cancer	2.29e-05	9.13e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—SRC—pancreatic cancer	2.29e-05	9.13e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.28e-05	9.13e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PIK3CB—pancreatic cancer	2.28e-05	9.11e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—EGFR—pancreatic cancer	2.27e-05	9.06e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—STAT3—pancreatic cancer	2.27e-05	9.05e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—NRAS—pancreatic cancer	2.26e-05	9.03e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GLP1R—pancreatic cancer	2.23e-05	8.91e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—VEGFA—pancreatic cancer	2.23e-05	8.89e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—STAT3—pancreatic cancer	2.2e-05	8.8e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—SRC—pancreatic cancer	2.2e-05	8.79e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—NRAS—pancreatic cancer	2.2e-05	8.78e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—DPYD—pancreatic cancer	2.2e-05	8.77e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CXCL8—pancreatic cancer	2.19e-05	8.75e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	2.19e-05	8.74e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—KRAS—pancreatic cancer	2.16e-05	8.63e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—VEGFA—pancreatic cancer	2.14e-05	8.56e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—KRAS—pancreatic cancer	2.14e-05	8.56e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—TYMP—pancreatic cancer	2.14e-05	8.53e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—STAT3—pancreatic cancer	2.12e-05	8.47e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3CB—pancreatic cancer	2.12e-05	8.47e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—NRAS—pancreatic cancer	2.12e-05	8.45e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MYC—pancreatic cancer	2.11e-05	8.41e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TGFB1—pancreatic cancer	2.1e-05	8.39e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CASP3—pancreatic cancer	2.1e-05	8.38e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	2.08e-05	8.32e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—TYMS—pancreatic cancer	2.08e-05	8.31e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.06e-05	8.24e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—EGFR—pancreatic cancer	2.06e-05	8.23e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MYC—pancreatic cancer	2.05e-05	8.18e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TGFB1—pancreatic cancer	2.04e-05	8.16e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCND1—pancreatic cancer	2.04e-05	8.15e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CXCL8—pancreatic cancer	2.04e-05	8.14e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—HRAS—pancreatic cancer	2.02e-05	8.08e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CTNNB1—pancreatic cancer	2.02e-05	8.07e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—EGFR—pancreatic cancer	2e-05	8e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.99e-05	7.95e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PIK3CA—pancreatic cancer	1.98e-05	7.93e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MMP9—pancreatic cancer	1.98e-05	7.92e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MYC—pancreatic cancer	1.97e-05	7.87e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PTEN—pancreatic cancer	1.97e-05	7.87e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—PIK3CA—pancreatic cancer	1.97e-05	7.86e-05	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—AKT1—pancreatic cancer	1.97e-05	7.86e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TGFB1—pancreatic cancer	1.97e-05	7.86e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CASP3—pancreatic cancer	1.95e-05	7.79e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—KRAS—pancreatic cancer	1.95e-05	7.77e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—EGFR—pancreatic cancer	1.93e-05	7.7e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TP53—pancreatic cancer	1.9e-05	7.61e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCND1—pancreatic cancer	1.9e-05	7.58e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—KRAS—pancreatic cancer	1.89e-05	7.56e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CTNNB1—pancreatic cancer	1.88e-05	7.51e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MMP9—pancreatic cancer	1.84e-05	7.36e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—HRAS—pancreatic cancer	1.84e-05	7.34e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PTEN—pancreatic cancer	1.83e-05	7.32e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—SRC—pancreatic cancer	1.83e-05	7.3e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—KRAS—pancreatic cancer	1.82e-05	7.28e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—HRAS—pancreatic cancer	1.82e-05	7.27e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.81e-05	7.24e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—PIK3CA—pancreatic cancer	1.79e-05	7.14e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—AKT1—pancreatic cancer	1.79e-05	7.14e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—VEGFA—pancreatic cancer	1.78e-05	7.11e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—STAT3—pancreatic cancer	1.76e-05	7.04e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NRAS—pancreatic cancer	1.76e-05	7.02e-05	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—AKT1—pancreatic cancer	1.75e-05	6.98e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PIK3CA—pancreatic cancer	1.74e-05	6.94e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TP53—pancreatic cancer	1.73e-05	6.91e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.72e-05	6.88e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—SRC—pancreatic cancer	1.7e-05	6.79e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.69e-05	6.77e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—APOE—pancreatic cancer	1.69e-05	6.76e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TP53—pancreatic cancer	1.68e-05	6.72e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PIK3CA—pancreatic cancer	1.67e-05	6.69e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—VEGFA—pancreatic cancer	1.65e-05	6.61e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—HRAS—pancreatic cancer	1.65e-05	6.61e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—STAT3—pancreatic cancer	1.64e-05	6.54e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MYC—pancreatic cancer	1.64e-05	6.54e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NRAS—pancreatic cancer	1.63e-05	6.53e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TGFB1—pancreatic cancer	1.63e-05	6.52e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—AKT1—pancreatic cancer	1.62e-05	6.48e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TP53—pancreatic cancer	1.62e-05	6.47e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CD44—pancreatic cancer	1.61e-05	6.44e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—HRAS—pancreatic cancer	1.61e-05	6.43e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—AKT1—pancreatic cancer	1.61e-05	6.42e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.61e-05	6.42e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—EGFR—pancreatic cancer	1.6e-05	6.4e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.58e-05	6.31e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.57e-05	6.25e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—HRAS—pancreatic cancer	1.55e-05	6.18e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GCG—pancreatic cancer	1.55e-05	6.18e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	1.53e-05	6.1e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MYC—pancreatic cancer	1.52e-05	6.08e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TGFB1—pancreatic cancer	1.52e-05	6.07e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KRAS—pancreatic cancer	1.51e-05	6.04e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—EGFR—pancreatic cancer	1.49e-05	5.95e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PPARG—pancreatic cancer	1.47e-05	5.89e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—AKT1—pancreatic cancer	1.46e-05	5.83e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—STK11—pancreatic cancer	1.45e-05	5.81e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—AKT1—pancreatic cancer	1.42e-05	5.67e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—KRAS—pancreatic cancer	1.41e-05	5.62e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PIK3CA—pancreatic cancer	1.39e-05	5.55e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—AKT1—pancreatic cancer	1.37e-05	5.46e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.37e-05	5.45e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TP53—pancreatic cancer	1.34e-05	5.37e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	1.34e-05	5.36e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3CA—pancreatic cancer	1.29e-05	5.16e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—HRAS—pancreatic cancer	1.29e-05	5.14e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—TYMS—pancreatic cancer	1.25e-05	5e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TP53—pancreatic cancer	1.25e-05	4.99e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CD44—pancreatic cancer	1.25e-05	4.97e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—HRAS—pancreatic cancer	1.2e-05	4.78e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GCG—pancreatic cancer	1.19e-05	4.77e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	1.17e-05	4.67e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTGS2—pancreatic cancer	1.16e-05	4.63e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—AKT1—pancreatic cancer	1.14e-05	4.54e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—STK11—pancreatic cancer	1.12e-05	4.48e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—AKT1—pancreatic cancer	1.06e-05	4.22e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—APOE—pancreatic cancer	1.02e-05	4.06e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTEN—pancreatic cancer	1.01e-05	4.04e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—TYMS—pancreatic cancer	9.65e-06	3.86e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.63e-06	3.85e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	9.18e-06	3.67e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PPARG—pancreatic cancer	8.86e-06	3.54e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	8.07e-06	3.22e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—APOE—pancreatic cancer	7.85e-06	3.14e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	7.13e-06	2.85e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	7.09e-06	2.83e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	7.04e-06	2.81e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTGS2—pancreatic cancer	6.97e-06	2.78e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PPARG—pancreatic cancer	6.84e-06	2.73e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	6.23e-06	2.49e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTEN—pancreatic cancer	6.08e-06	2.43e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—AKT1—pancreatic cancer	5.83e-06	2.33e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	5.43e-06	2.17e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTGS2—pancreatic cancer	5.38e-06	2.15e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTEN—pancreatic cancer	4.69e-06	1.87e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	4.29e-06	1.71e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—AKT1—pancreatic cancer	3.5e-06	1.4e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	3.31e-06	1.32e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.7e-06	1.08e-05	CbGpPWpGaD
